Literature DB >> 30616208

Seizures as an early symptom of autosomal dominant Alzheimer's disease.

Jonathan Vöglein1, Soheyl Noachtar2, Eric McDade3, Kimberly A Quaid4, Stephen Salloway5, Bernardino Ghetti6, James Noble7, Sarah Berman8, Jasmeer Chhatwal9, Hiroshi Mori10, Nick Fox11, Ricardo Allegri12, Colin L Masters13, Virginia Buckles3, John M Ringman14, Martin Rossor11, Peter R Schofield15, Reisa Sperling9, Mathias Jucker16, Christoph Laske17, Katrina Paumier3, John C Morris3, Randall J Bateman3, Johannes Levin18, Adrian Danek19.   

Abstract

Our objective was to assess the reported history of seizures in cognitively asymptomatic mutation carriers for autosomal dominant Alzheimer's disease (ADAD) and the predictive value of seizures for mutation carrier status in cognitively asymptomatic first-degree relatives of ADAD patients. Seizure occurrence in the Dominantly Inherited Alzheimer Network observational study was correlated with mutation carrier status in cognitively asymptomatic subjects. Of 276 cognitively asymptomatic individuals, 11 (4%) had experienced seizures, and nine of these carried an ADAD mutation. Thus, in the Dominantly Inherited Alzheimer Network population, seizure frequency in mutation carriers was significantly higher than in noncarriers (p = 0.04), and the positive predictive value of seizures for the presence of a pathogenic mutation was 81.8%. Among cognitively asymptomatic ADAD family members, the occurrence of seizures increases the a priori risk of 50% mutation-positive status to about 80%. This finding suggests that ADAD mutations increase the risk of seizures.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Autosomal dominant; Dementia; Genetics; Positive predictive value; Seizures

Mesh:

Year:  2018        PMID: 30616208      PMCID: PMC6572755          DOI: 10.1016/j.neurobiolaging.2018.11.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   5.133


  24 in total

1.  CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.

Authors:  Carlos Velez-Pardo; Jon I Arellano; Patricia Cardona-Gomez; Marlene Jimenez Del Rio; Francisco Lopera; Javier De Felipe
Journal:  Epilepsia       Date:  2004-07       Impact factor: 5.864

2.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

Review 3.  Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

4.  Incidence and predictors of seizures in patients with Alzheimer's disease.

Authors:  Joan C Amatniek; W Allen Hauser; Carrie DelCastillo-Castaneda; Diane M Jacobs; Karen Marder; Karen Bell; Marilyn Albert; Joseph Brandt; Yaakov Stern
Journal:  Epilepsia       Date:  2006-05       Impact factor: 5.864

Review 5.  The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution.

Authors:  Chrysostomos P Panayiotopoulos
Journal:  Epilepsia       Date:  2012-01-13       Impact factor: 5.864

6.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

Review 7.  Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?

Authors:  A J Larner
Journal:  Epilepsy Behav       Date:  2011-04-17       Impact factor: 2.937

8.  Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures.

Authors:  M Takao; B Ghetti; J R Murrell; F W Unverzagt; G Giaccone; F Tagliavini; O Bugiani; P Piccardo; C M Hulette; B J Crain; M R Farlow; A Heyman
Journal:  J Neuropathol Exp Neurol       Date:  2001-12       Impact factor: 3.685

Review 9.  The epidemiology of epilepsy revisited.

Authors:  Josemir W Sander
Journal:  Curr Opin Neurol       Date:  2003-04       Impact factor: 5.710

10.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

View more
  8 in total

1.  Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.

Authors:  William L Neumann; Karin E Sandoval; Shirin Mobayen; Mahsa Minaeian; Stephen G Kukielski; Khush N Srabony; Rafael Frare; Olivia Slater; Susan A Farr; Michael L Niehoff; Audrey Hospital; Maria Kontoyianni; A Michael Crider; Ken A Witt
Journal:  RSC Med Chem       Date:  2021-05-26

2.  Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.

Authors:  Johannes Levin; Jonathan Vöglein; Yakeel T Quiroz; Randall J Bateman; Valentina Ghisays; Francisco Lopera; Eric McDade; Eric Reiman; Pierre N Tariot; John C Morris
Journal:  Alzheimers Dement       Date:  2022-02-24       Impact factor: 16.655

Review 3.  Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.

Authors:  Miren Altuna; Gonzalo Olmedo-Saura; María Carmona-Iragui; Juan Fortea
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

4.  Upregulated expression of a subset of genes in APP;ob/ob mice: Evidence of an interaction between diabetes-linked obesity and Alzheimer's disease.

Authors:  Mitsuru Shinohara; Masataka Kikuchi; Miyuki Onishi-Takeya; Yoshitaka Tashiro; Kaoru Suzuki; Yasuhiro Noda; Shuko Takeda; Masahiro Mukouzono; Seiichi Nagano; Akio Fukumori; Ryuichi Morishita; Akihiro Nakaya; Naoyuki Sato
Journal:  FASEB Bioadv       Date:  2021-03-02

Review 5.  Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.

Authors:  Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.

Authors:  Jonathan Vöglein; Katrina Paumier; Mathias Jucker; Oliver Preische; Eric McDade; Jason Hassenstab; Tammie L Benzinger; James M Noble; Sarah B Berman; Neill R Graff-Radford; Bernardino Ghetti; Martin R Farlow; Jasmeer Chhatwal; Stephen Salloway; Chengjie Xiong; Celeste M Karch; Nigel Cairns; Hiroshi Mori; Peter R Schofield; Colin L Masters; Alison Goate; Virginia Buckles; Nick Fox; Martin Rossor; Patricio Chrem; Ricardo Allegri; John M Ringman; Günter Höglinger; Harald Steiner; Marianne Dieterich; Christian Haass; Christoph Laske; John C Morris; Randall J Bateman; Adrian Danek; Johannes Levin
Journal:  Brain       Date:  2019-05-01       Impact factor: 15.255

Review 7.  The clinical correlation between Alzheimer's disease and epilepsy.

Authors:  Dandan Zhang; Siyuan Chen; Shoucheng Xu; Jing Wu; Yuansu Zhuang; Wei Cao; Xiaopeng Chen; Xuezhong Li
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

8.  Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.

Authors:  Jonathan Vöglein; Ingrid Ricard; Soheyl Noachtar; Walter A Kukull; Marianne Dieterich; Johannes Levin; Adrian Danek
Journal:  J Neurol       Date:  2020-06-02       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.